Board Meeting20 Jul 2026, 06:30 pm
Onesource Specialty Pharma Board Meeting on July 24, 2026
AI Summary
Onesource Specialty Pharma Ltd has announced that its Board of Directors will convene on July 24, 2026. The primary agenda item is to consider and approve the unaudited financial results, both standalone and consolidated, for the quarter ended June 30, 2026. Additionally, the company will address other business matters. In line with SEBI regulations, the trading window for designated persons will remain closed from July 1, 2026, and will reopen 48 hours after the financial results are disseminated.
Key Highlights
- Board meeting scheduled for July 24, 2026.
- To approve unaudited financial results for Q1 FY27.
- Results will be standalone and consolidated.
- Trading window closure in effect for designated persons.
- Window reopens 48 hours post-results dissemination.
Price Impact
More from ONESOURCE